Dj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 11.84 Cr
- Revenue Growth 14.07%
- Profit Growth -269.92%
- Ebitda 2.11%
- Net Worth 26.56%
- Total Assets 30.65%
About Dj Pharmaceuticals
Dj Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2016 (Eight years and five months 11 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹11.84 Cr.
Vishnukumar Danidhariya, Babubhai Patel, and Devendra Dudhrejia serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304GJ2016PTC093512
-
Company No.
093512
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2016
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Dj Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnukumar Danidhariya
|
Director | 29-Aug-2016 | Current |
|
Babubhai Patel
|
Director | 29-Aug-2016 | Current |
|
Devendra Dudhrejia
|
Director | 19-Feb-2021 | Current |
Financial Performance of Dj Pharmaceuticals.
Dj Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.07% increase. The company also saw a substantial fall in profitability, with a 269.92% decrease in profit. The company's net worth Soared by an impressive increase of 26.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dj Pharmaceuticals?
In 2020, Dj Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dj Lifescience Private LimitedVishnukumar Danidhariya is a mutual person
-
Dj Alloys Private LimitedVishnukumar Danidhariya is a mutual person
Charges (Loans)
₹11.84 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 11.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2017 | State Bank Of India | ₹11.84 Cr | Open |
How Many Employees Work at Dj Pharmaceuticals?
Unlock and access historical data on people associated with Dj Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
